Dr. Vivek Iyer MBBS , MD (Paediatrics), NALS, PALS
Zydus Hospital
21 Years Experience
Dr. Vivek Iyer – Senior Consultant Paediatrician
MBBS, MD (Paediatrics), NALS, PALS
When a child is unwell, parents often have many questions. Is the fever something to worry about? Is the baby gaining enough weight? Why does the same cough keep coming back? Sometimes, even a small change in a child’s behaviour can leave parents concerned.
Dr. Vivek K. Iyer is a Senior Consultant Paediatrician with more than 21 years of experience in child healthcare. He treats newborns, children and teenagers with a wide range of health concerns. His experience covers everyday childhood illnesses, newborn care, infections, emergencies and long-term health conditions.
Professional Summary
Dr. Vivek K. Iyer is an experienced paediatrician with qualifications including MBBS, MD (Paediatrics), NALS and PALS. His areas of care include general paediatrics, neonatal care, childhood infections, adolescent medicine and paediatric emergencies.
For parents, visiting a paediatrician is not always about treating an illness. There may be questions about a child’s weight, height, eating habits, vaccinations or development. He provides guidance on these concerns as well.
He looks at the child’s age, symptoms and overall health before suggesting the next steps. This helps parents better understand what may be happening and what kind of care their child may need.
Hospital Affiliation
Dr. Vivek Iyer is associated with Zydus Hospital, Ahmedabad, where he works as a Senior Consultant Paediatrician.
Zydus Hospital is an NABH-accredited multi-specialty hospital. It has facilities for paediatric and neonatal care, including units for children and newborn babies. Paediatric emergency services, vaccination support and diagnostic facilities are also available at the hospital.
Areas of Paediatric Care
Comprehensive Paediatric Care
Paediatric Emergency and Critical Care
Neonatal Care
Paediatric Infectious Diseases
Adolescent Medicine
Chronic Paediatric Conditions
Why Consult Dr. Vivek Iyer?
- More than 21 years of paediatric experience
- Care for newborns, children and teenagers
- Routine and emergency paediatric care
- Vaccination and preventive health guidance
- Growth and development assessments
- Management of chronic childhood conditions
- Guidance for parents about their child’s health
Languages Spoken:
- English (Fluent)
- Hindi (Fluent)
- Gujarati (Fluent)
Paediatric Consultation Services Available Through Reopine
Not every concern starts with an emergency. Sometimes, parents simply need to ask a doctor about a symptom, report or ongoing treatment.
Through Reopine, parents can consult Dr. Vivek Iyer for different paediatric concerns. These may include first opinions, second opinions, vaccination guidance, growth and development concerns and support for chronic conditions.
Parents can also discuss feeding problems, nutrition, developmental concerns and follow-up care.
Last Updated: October 2025
Profile prepared for Reopine
Date: 17 Nov 2026
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 17 Nov 2026
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.